The MAPK/ERK signaling pathway is an additional crucial target for inhibitors. Inhibitors targeting MAPK/ERK are utilized in cancer cells treatments to protect against unrestrained cell expansion and tumor development.Anti-infection inhibitors incorporate a broader array of agents that target different microorganisms such as fungi, infections, and